The Role of Wilms’ Tumor Gene (WT1) Expression as a Marker of Minimal Residual Disease in Acute Myeloid Leukemia

The Minimal Residual Disease(MRD) monitoring in acute myeloid leukemia (AML) is crucial to guide treatment after morphologic complete remission, to define the need for consolidation with allogeneic stem cell transplantation (Allo-SCT), and to detect impending relapse allowing early intervention. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazzarotto, Davide, Candoni, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225390/
https://www.ncbi.nlm.nih.gov/pubmed/35743376
http://dx.doi.org/10.3390/jcm11123306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225390/
https://www.ncbi.nlm.nih.gov/pubmed/35743376
http://dx.doi.org/10.3390/jcm11123306

Ejemplares similares